MedTrace Logo

Black Cohosh Extract in Postmenopausal Breast Health

NCT00064831 · Status: COMPLETED · Phase: PHASE1/PHASE2 · Type: INTERVENTIONAL · Enrollment: 73

Last updated 2007-12-07

No results posted yet for this study

Summary

The purpose of the study is to determine if black cohosh extract (BCE) administration in symptomatic postmenopausal women results in estrogenic stimulation of the breast, as determined by estradiol, pS2, FSH, LH, and PSA levels in nipple aspirate fluid.

Conditions

Interventions

DRUG

Black Cohosh Extract (BCE)

Sponsors & Collaborators

  • University of Missouri-Columbia

    collaborator OTHER

  • National Center for Complementary and Integrative Health (NCCIH)

    lead NIH

Principal Investigators

  • Edward Sauter, MD · University of Missouri-Columbia

Study Design

Allocation
NON_RANDOMIZED
Purpose
PREVENTION
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2003-07-31
Completion
2007-02-28

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00064831 on ClinicalTrials.gov